Johnson & Johnson (BMV:JNJ)

Mexico flag Mexico · Delayed Price · Currency is MXN
2,960.00
-28.84 (-0.96%)
Last updated: Jun 4, 2025
12.66%
Market Cap 7.09T
Revenue (ttm) 1.83T
Net Income (ttm) 445.58B
Shares Out n/a
EPS (ttm) 183.56
PE Ratio 15.90
Forward PE 14.50
Dividend 99.35 (3.36%)
Ex-Dividend Date May 27, 2025
Volume 3,170
Average Volume 3,480
Open 2,960.00
Previous Close 2,988.84
Day's Range 2,960.00 - 2,960.00
52-Week Range 2,555.00 - 3,535.00
Beta 0.41
RSI 42.64
Earnings Date Jul 16, 2025

About Johnson & Johnson

Johnson & Johnson, together with its subsidiaries, engages in the research and development, manufacture, and sale of various products in the healthcare field worldwide. It operates in two segments, Innovative Medicine and MedTech. The Innovative Medicine segment offers products for various therapeutic areas, such as immunology, including rheumatoid arthritis, psoriatic arthritis, inflammatory bowel disease, and psoriasis; infectious diseases comprising HIV/AIDS; neuroscience, consisting of mood disorders, neurodegenerative disorders, and schizo... [Read more]

Sector Healthcare
Founded 1886
Employees 138,100
Stock Exchange Mexican Stock Exchange
Ticker Symbol JNJ
Full Company Profile

Financial Performance

In 2024, Johnson & Johnson's revenue was $88.82 billion, an increase of 4.30% compared to the previous year's $85.16 billion. Earnings were $14.07 billion, a decrease of -59.99%.

Financial numbers in USD Financial Statements

News

There is no news available yet.